The Effect of Manual Acupuncture and Standard Therapy on Anxiety and Quality of Life Scores in Cancer Patients
1 other identifier
interventional
38
1 country
2
Brief Summary
The goal of this clinical trial is to prove that the combination of acupuncture therapy and standard therapy is more effective in reducing anxiety and improving the quality of life of cancer patients. The main questions it aims to answer are:
- 1.Can the combination of manual acupuncture and standard therapy reduce anxiety based on Hamilton Anxiety Rating Scale (HAM-A) scores in cancer patients compared to the sham acupuncture and standard therapy group?
- 2.Can the combination of manual acupuncture and standard therapy improve the quality of life of cancer patients based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C-30 (EORTC-QLQ C30) compared to the sham acupuncture and standard therapy group?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started Mar 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2024
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedStudy Start
First participant enrolled
March 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedJanuary 8, 2026
January 1, 2026
8 months
December 23, 2024
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Hamilton anxiety rating scale (HAM-A) score
One tool to measure the degree of anxiety symptoms is a questionnaire. Scores range from 0-56.
6 days
Secondary Outcomes (1)
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C-30 (EORTC-QLQ C30) score
6 days
Study Arms (2)
Intervention Group
EXPERIMENTALThe manual acupuncture and standard therapy
Control Group
SHAM COMPARATORThe sham acupuncture and standard therapy
Interventions
Manual acupuncture is acupuncture needle insertion was done perpendicularly to the acupuncture points GV20, EXHN3, HT7, and PC6 using Huanqiu needle measuring 0.25 x 25mm with mild stimulation rotation technique at a speed of 60x/minute and needle retention for 30 minutes. Therapy was performed every day for 6 days. Standard therapy is anxiolytic drugs and supportive psychotherapy given to patients according to the decision of the psychiatrist treating the patient.
Sham acupuncture is when acupuncture needles are inserted into acupuncture points, but do not actually penetrate the skin, only attached to the plaster. Therapy was performed every day for 6 days. Standard therapy is anxiolytic drugs and supportive psychotherapy given to patients according to the decision of the psychiatrist treating the patient.
Eligibility Criteria
You may qualify if:
- Patients aged 18-59 years.
- Diagnosed with cancer in the last 6 months
- Experiencing moderate to severe anxiety (assessed by HAM-A Score \> 14)
- Willing to participate in this study until completion and sign an informed consent.
You may not qualify if:
- Cancer patients with unstable hemodynamics
- Cancer patients with brain metastases
- Patients who have been diagnosed with anxiety disorders and have received pharmacological therapy from psychiatrists before.
- Patients who have contraindications to manual acupuncture (there are wounds or infections at the point to be punctured, patients are allergic to stainless steel, patients are phobic of needles)
- Patients who are uncooperative and do not allow acupuncture therapy (patients who are restless, angry)
- Patients with poor liver function (SGOT (Serum Glutamic Oxaloacetic Transaminase) /SGPT (serum glutamate pyruvate transaminase)values increase 2-3 times the normal value)
- Patients with blood clotting disorders (platelets \<50,000, INR (International Normalized Ratio) \> 2)
- Patients with neutropenia (Absolute neutrophil count \<1000)
- Patients with overt DIC (disseminated intravascular coagulation) and acute venous or arterial thrombosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universitas Indonesia
Jakarta Pusat, DKI Jakarta, 10430, Indonesia
RS Kanker Dharmais
Jakarta, 11420, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
KEPK FKUI-RSCM
The Health Research Ethics Commitee of Faculty of Medicine
- PRINCIPAL INVESTIGATOR
KEPK RS Kanker Dharmais
The Health Research Ethics Commitee of Dharmais Cancer Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The participants, and outcome assessors will be blinded to group allocation
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
December 23, 2024
First Posted
January 10, 2025
Study Start
March 24, 2025
Primary Completion
November 15, 2025
Study Completion
November 30, 2025
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share